ACE rs4316: Exercise Duration and Cardiovascular Response
The rs4316 single nucleotide polymorphism is located within the angiotensin-converting enzyme (ACE) gene on chromosome 17. Research has investigated this variant as a genetic marker modulating baseline exercise capacity and cardiovascular training adaptations. Evidence supporting these associations is considered moderate, reflecting modest statistical tendencies across diverse population cohorts rather than direct physiological determinants.
What each genotype means
Baseline exercise test duration
You carry two copies of the C allele for rs4316 in the ACE gene. Cohort research, such as the CARDIA fitness study, observed that individuals with this homozygous baseline genotype had slightly shorter average treadmill exercise test durations compared to carriers of the T allele. These differences represent modest statistical shifts in exercise duration rather than a barrier to cardiorespiratory fitness.
Carried by approximately 30% to 40% of individuals in African and European populations, but less common in East Asian ancestry groups where the T allele is more prevalent.
Intermediate exercise duration profile
You carry one C allele and one T allele at rs4316 in the ACE gene. Population studies examining fitness markers have linked the heterozygous genotype to intermediate treadmill test performance compared to homozygous genotypes. Overall exercise capacity is heavily influenced by regular training, cardiovascular conditioning, and broad lifestyle factors beyond single genetic variations.
Found in approximately 45% to 50% of individuals across multiple global populations, making it the most frequent genotype.
Favorable baseline exercise duration
You carry two copies of the minor T allele at rs4316 in the ACE gene. Published fitness association studies have identified this genotype as nominally associated with longer baseline symptom-limited treadmill exercise test durations. However, the effect size is small and accounts for only a minor fraction of overall endurance performance.
Carried by roughly 15% to 20% of people of European and African ancestry, and upwards of 40% in East Asian populations where the T allele occurs at a higher frequency.
Understanding rs4316 and the ACE Gene
The rs4316 variant is a coding-region single nucleotide variant located within the human ACE gene on chromosome 17q23.3. The ACE gene encodes the angiotensin-converting enzyme, an essential catalytic component of the renin-angiotensin-aldosterone system (RAAS). This biochemical cascade plays a foundational role in vascular tone, blood pressure regulation, fluid balance, and cardiac remodeling. Systemically and within local tissues like skeletal and cardiac muscle, ACE cleaves angiotensin I into the potent vasoconstrictor angiotensin II while simultaneously degrading the vasodilator peptide bradykinin. Genetic variation across the ACE locus can influence circulating enzyme levels or tissue-level enzymatic activity. Within population genetics, rs4316 is frequently analyzed either directly or as part of larger haplotype blocks alongside the historical 287-base-pair insertion/deletion (I/D) polymorphism in intron 16. Because of its coding position, rs4316 serves as an informative genomic tag for studying how subtle variations in enzyme activity correlate with physical performance and cardiovascular phenotypes.
Exercise Duration and Training Adaptation
Scientific investigation into rs4316 has predominantly focused on human physical performance, baseline exercise test duration, and cardiorespiratory adaptations to aerobic and resistance training. Classical exercise genomics demonstrates that lower systemic ACE activity tends to correlate with enhanced metabolic efficiency and aerobic endurance capacity, whereas higher activity favors muscle hypertrophy, power, and cardiac structural growth. In observational exercise trials, individuals carrying specific alleles at rs4316 have exhibited minor statistical differences in time-to-exhaustion treadmill protocols, baseline exercise performance, and hemodynamic responses following structured training regimens. However, these associations represent moderate statistical signals rather than definitive physiological switches. The overall contribution of a single nucleotide change to complex athletic phenotypes is small. Training adaptation, maximal oxygen uptake (VO2 max), and muscular endurance are polygenic traits governed by hundreds of interconnected genetic loci interacting alongside lifestyle factors like nutrition, training intensity, sleep, and environmental context.
Evaluating the Scientific Evidence and Limitations
The strength of evidence linking rs4316 directly to exercise duration and training adaptation is classified as moderate. While the broader biological role of ACE in vascular regulation and exercise physiology is well established, candidate-gene association studies historically suffer from small sample sizes, publication bias, and difficulty replicating findings across diverse ancestral cohorts. Many early findings derived from European cohorts did not replicate uniformly in other populations, partly due to varying linkage disequilibrium architectures across the ACE gene locus. Furthermore, genome-wide association studies (GWAS) for cardiorespiratory fitness have highlighted that athletic potential and training responsiveness cannot be predicted accurately by isolated markers. Consequently, rs4316 should be viewed as an informative marker in observational research rather than a standalone functional variant capable of altering human physiological capacity on its own.
Interpreting Your Genetic Data Responsibly
Encountering rs4316 on a commercial genetic report or consumer DNA platform can be informative, but it should not dictate personal fitness routines or medical decisions. Carriage of any genotype at this locus does not guarantee superior endurance performance, nor does it create a barrier to achieving significant cardiovascular fitness. Regular physical activity induces favorable metabolic, cardiovascular, and muscular adaptations regardless of an individual's ACE genotype. Additionally, because ACE is an important target for antihypertensive pharmacology—such as ACE inhibitors used to manage hypertension and heart failure—some consumers may wonder if rs4316 alters medication efficacy. Clinical pharmacogenetic guidelines from standard consortiums currently do not recommend modifying ACE inhibitor prescriptions based solely on rs4316 status. Readers should always discuss medication management, blood pressure targets, and intensive training programs directly with a qualified physician or healthcare provider.
How common is this variant?
The rs4316 variant is a common single nucleotide polymorphism globally, displaying an overall minor allele frequency of approximately 0.42 according to large reference cohorts in the Genome Aggregation Database (gnomAD).
Frequently asked questions
Can my rs4316 genotype predict whether I will be good at endurance sports?
No, your rs4316 genotype cannot determine whether you will excel as an endurance athlete. Human physical performance is a complex polygenic trait influenced by thousands of genetic loci interacting with training consistency, diet, mental discipline, and recovery. Research on rs4316 reflects modest population-level trends rather than individualized predictive outcomes.
Does rs4316 mean I should alter my exercise routine?
No. Everyone benefits from regular aerobic and resistance exercise regardless of their ACE genotype. Tailoring your workout routine should be based on your personal fitness goals, physical capabilities, and guidance from certified exercise professionals rather than a single genetic variant.
Does this genetic variant affect blood pressure medications like ACE inhibitors?
Currently, clinical guidelines like CPIC do not recommend modifying blood pressure medication selection or dosing based on rs4316. While ACE is a pharmacological target, medication response is complex. Any questions or adjustments regarding cardiovascular medications should be addressed directly with your prescribing physician or pharmacist.
How does rs4316 relate to the well-known ACE insertion/deletion (I/D) polymorphism?
The rs4316 variant resides in the same gene as the widely studied ACE insertion/deletion (I/D) polymorphism. In many ancestral populations, single nucleotide variants across the ACE locus are in linkage disequilibrium with the I/D variant, meaning they tend to be inherited together and serve as genomic tags for regional genetic variation.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4316?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ACE
This variant is associated with ACE activity levels, though current CPIC guidelines prioritize other markers for clinical ACE inhibitor dosing.
The ACE I/D polymorphism (rs1799752) is associated with circulating ACE activity, physical performance, and ACE inhibitor-induced cough.
Exonic variant in ACE often used as a proxy for the ACE insertion/deletion polymorphism affecting circulating ACE enzyme activity.
This variant in the ACE gene is associated with variations in soluble amyloid-beta levels in patients with Alzheimer's disease.
This SNP is being investigated as a potential biomarker for personalized antihypertensive therapy in specific ethnic cohorts.
A variant recently evaluated in pharmacogenomic studies of the Pashtun population to assess its role in antihypertensive drug response.